For many people living with Crohn’s disease, the word “surgery” can feel like a setback, as though medication has failed. In reality, surgery is often a planned and effective part of long-term management, not a last resort reserved for emergencies. Understanding when and why it might be recommended can help take some of the fear out of the conversation.
What is surgery’s role in Crohn’s disease?
Crohn’s disease is a form of inflammatory bowel disease (IBD) that can affect any part of the digestive tract, causing patches of inflammation that may lead to scarring, narrowing, or abnormal connections between the bowel and nearby tissue. Surgery does not cure Crohn’s disease, since inflammation can return elsewhere in the gut after an operation. Instead, surgery removes or repairs the specific section of bowel that is causing problems, giving the rest of the digestive system a chance to function normally while medical treatment continues.
Why it matters for gut inflammation
Long-standing inflammation damages the layers of the bowel wall. Repeated cycles of injury and healing can cause the tissue to thicken and stiffen, forming a stricture (a narrowed section that restricts the passage of digested food). In other cases, inflammation can burrow through the full thickness of the bowel wall, creating a fistula (an abnormal tunnel connecting two body parts) or an abscess (a localised pocket of infection). These structural changes are not always reversible with medication alone, which is why surgery sometimes becomes necessary even when a person is otherwise responding to treatment.
Key mechanisms and clinical scenarios
Stricturing disease
When scar tissue narrows the bowel, medications that reduce inflammation cannot undo the physical narrowing. If a stricture causes recurring blockages, bloating, or pain after eating, surgical removal of that segment (a resection) or a widening procedure (a strictureplasty) can restore normal passage. This is one of the most common reasons for planned Crohn’s surgery.
Fistulising and perianal disease
Fistulas around the anus or between loops of bowel can cause persistent discharge, pain, or recurrent infection. While some fistulas respond to anti-tumour necrosis factor (anti-TNF) therapy, a class of biologic medication that blocks a key inflammatory protein, others require surgical drainage or the placement of a seton (a soft thread used to keep a fistula open and controlled) alongside medical treatment.
Medically refractory inflammation
When inflammation remains active despite trying multiple appropriate medications, ongoing damage to the bowel and reduced quality of life can outweigh the benefits of continuing to escalate drug therapy. In this context, removing the affected segment can achieve a level of symptom control and disease remission that medication alone has not provided.
Acute complications
Some situations require urgent surgery regardless of how well-controlled the disease has generally been. A bowel perforation (a hole through the bowel wall), significant bleeding, or an abscess that cannot be drained by other means are examples where prompt surgical intervention is necessary to protect health and prevent more serious illness.
Cancer risk in long-standing disease
In cases of long-standing Crohn’s disease affecting the colon, there is a modestly increased risk of colorectal changes over many years. Surveillance colonoscopy helps monitor this, and in some cases where concerning changes are found, surgery may be recommended as a preventive measure.
Weighing the decision
Deciding on surgery involves balancing the extent of bowel damage, how well symptoms are controlled, the person’s nutritional status, and their own priorities and lifestyle. It is worth remembering that symptoms do not always reflect the level of inflammation present. Some people have significant bowel damage with relatively mild symptoms, while others feel unwell with only modest inflammation. This is why decisions are usually guided by a combination of symptoms, blood tests, imaging, and endoscopic findings, discussed jointly between the patient, gastroenterologist, and colorectal surgeon. Surgery is not a sign that treatment has failed; it is one of several tools used to manage a condition that behaves differently in each person.
Practical takeaways
- Keep track of symptoms such as pain after eating, bloating, or changes in bowel habit, and report patterns rather than isolated episodes.
- Attend recommended imaging and colonoscopy appointments, as these help detect structural changes before they cause complications.
- Ask questions if surgery is mentioned, including what type of procedure is being considered and what recovery and recurrence risk might look like.
- Continue any prescribed medication as directed, even if surgery is being discussed, unless a clinician advises otherwise.
- Maintain good nutrition and, where possible, address any deficiencies before a planned operation, as this supports recovery.
- Discuss long-term monitoring plans after surgery, since inflammation can return in a different part of the bowel over time.
Conclusion
Surgery for Crohn’s disease is best understood as a targeted response to structural problems, such as strictures, fistulas, or damage that medication cannot resolve, rather than a failure of treatment. Many people who undergo surgery experience a meaningful improvement in symptoms and quality of life, particularly when it is planned rather than performed as an emergency. Ongoing medical therapy and monitoring after surgery remain important, since Crohn’s disease can recur elsewhere in the digestive tract. Working closely with a gastroenterology and surgical team helps ensure that any decision about surgery is made at the right time and for the right reasons. Long-term stability, rather than a single procedure, remains the overall goal of management.
References
- Ponsioen CY, de Groof EJ, Eshuis EJ, et al. Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn’s disease: a randomised controlled, open-label, multicentre trial. Lancet Gastroenterol Hepatol. 2017;2(11):785-792. doi:10.1016/S2468-1253(17)30248-0.
- de Groof EJ, Stevens TW, Eshuis EJ, et al. Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C trial. Gut. 2019;68(10):1774-1780. doi:10.1136/gutjnl-2018-317539.
- Frolkis AD, Dykeman J, Negrón ME, et al. Cumulative incidence of second intestinal resection in Crohn’s disease: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109(11):1739-1748. doi:10.1038/ajg.2014.297.
- Bemelman WA, Allez M. The surgical intervention: earlier or never? Best Pract Res Clin Gastroenterol. 2014;28(3):497-503. doi:10.1016/j.bpg.2014.04.011.
- Bemelman WA, Warusavitarne J, Sampietro GM, et al. ECCO-ESCP consensus on surgery for Crohn’s disease. J Crohns Colitis. 2018;12(1):1-16. doi:10.1093/ecco-jcc/jjx061.
- Rutgeerts P, Geboes K, Vantrappen G, et al. Predictability of the postoperative course of Crohn’s disease. Gastroenterology. 1990;99(4):956-963. doi:10.1016/0016-5085(90)90613-6.
This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.